Home › Kanser ng Endometrium › Louisiana
Pag-aaral pangklinika para sa Kanser ng Endometrium sa Louisiana
15 pag-aaral para sa Kanser ng Endometrium ang naghahanap ng mga kalahok sa mga site sa Louisiana.
Mga Lungsod sa Louisiana
Opisyal na teksto ng pag-aaral (English)
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- West Jefferson Medical Center, Marrero
- East Jefferson General Hospital, Metairie
- LSU Healthcare Network / Metairie Multi-Specialty Clinic, Metairie
- at 1 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Okt 5, 2026 · NCT07198074Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Ochsner Medical Center Jefferson, New Orleans
Nagre-recruitPhase 2
Lahat ng edad · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05564377Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
- Ochsner Clinic Foundation, New Orleans
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Kababaihan · Na-update Set 29, 2026 · NCT05051722Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
- University Medical Center New Orleans, New Orleans
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Set 24, 2026 · NCT05640999A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
- WK Cancer Center, Shreveport
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Set 17, 2026 · NCT06340568A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Women's Cancer Care ( Site 6010), Covington
- TRIALS 365 ( Site 6005), Shreveport
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Set 17, 2026 · NCT06952504ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Tulane Cancer Center, New Orleans
- Christus Highland/ Boniol, Shreveport
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT05059444Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
- OLOL Cancer Institute, Baton Rouge
- Trials365, LLC, Shreveport
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Set 9, 2026 · NCT07166094DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, Shreveport
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Set 3, 2026 · NCT06989112A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
- LSU Health Sciences, New Orleans
- Trials365, LLC, Shreveport
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Ago 21, 2026 · NCT05548296A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Our Lady of the Lake, Baton Rouge
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT04657068Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
- Trials365 LLC, Shreveport
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Hul 28, 2026 · NCT07022483First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Louisiana State University Health Sciences Center, New Orleans
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT05768139A Study of Lorigerlimab in Participants With Advanced Solid Tumors
- Ochsner MD Anderson Cancer Center, New Orleans
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Hun 2, 2026 · NCT06730347SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, New Orleans
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.